Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · STAAR Surgical (STAA)

STAAR Surgical raises Alcon merger price to $30.75 per share in cash from $28.00

Positive Impact 5 of 5 m&a Written later

STAAR Surgical entered Amendment No. 2 to its merger agreement with Alcon Research, LLC and Rascasse Merger Sub, Inc. on December 9, 2025. The amendment raises the cash consideration for each STAAR common share to $30.75 from $28.00 if the merger is completed, and changes how certain equity awards and 280G tax gross-ups are handled.

Key points

  • Merger consideration increased to $30.75 per share in cash, without interest, from $28.00 per share
  • Amendment converts certain restricted stock units and performance-based awards into Alcon Inc. restricted stock units, with performance deemed earned at 100% of target
  • Amendment eliminates 280G gross-ups and related tax indemnification arrangements; director awards vest at closing

The filing

CompanySTAAR Surgical (STAA)
Form8-K, current report
Filed with the SECDec 9, 2025, 8:30 AM ET
Accession number0001193125-25-311982

Items reported: 1.01 Material Definitive Agreement

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:59 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 09, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.